Company
We’re Horizon, a global biopharmaceutical company driven by a simple idea: we believe that science and compassion must work together to transform lives.
Pipeline
Our pipeline is built on purpose, and our scientific courage drives us to tackle many marginalized, overlooked or forgotten diseases.
Medicines
At Horizon, we’re driven by a clear purpose; to improve patients’ lives. And the clearest expression of that purpose is the portfolio of medicines we offer to treat rare and rheumatic diseases.
News
01/11/2021
Horizon Therapeutics plc Provides Preliminary 2020 Financial Results, Exceeding Full-Year 2020 Net Sales and Adjusted EBITDA Guidance; Provides Update on TEPEZZA® (teprotumumab-trbw) Supply and New KRYSTEXXA® (pegloticase injection) Trials
12/22/2020
Horizon Therapeutics plc to Present at the 39th Annual J.P. Morgan Healthcare Conference